China NMPA Drug Inspection - Shaanxi Yishengtang Pharmaceutical Co., Ltd. - Berberine Hydrochloride Tablets
China NMPA drug inspection for Shaanxi Yishengtang Pharmaceutical Co., Ltd. published December 15, 2021. Drug: Berberine Hydrochloride Tablets. In December 2021, the Heilongjiang Provincial Drug Administration released Announcement No. 16, detailing results from i
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Shaanxi Yishengtang Pharmaceutical Co., Ltd. published December 15, 2021. Drug: Berberine Hydrochloride Tablets. In December 2021, the Heilongjiang Provincial Drug Administration released Announcement No. 16, detailing results from i
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox